IRENE CAESAR, PH.D.
Wavegenome
Irene Caesar, Ph.D. is a President and Founder of WAVE GENOME. She has founded WAVE GENOME in 2010 in Stamford, Connecticut, to lead the global QUANTUM LEAP in Laser Bioholography, Holonet (Holographic Biointernet), holographic drugs, Remote Bioengineering, and bioelectronics. WAVE GENOME is an American company, located now in Manchester, Connecticut, which is proud to be the leading competitor of major players in the field of bioelectronics, such as Elon Musk with his Neuralink, and Google with its R&D race for bioelectronic drugs. WAVE GENOME is ahead of Google for 8 years of actual sales and 50 years beyond R&D.
